Global Bronchial Thermoplasty Catheter Market to Observe Widespread Growth with Increasing Cases of Asthma

With significant developments in inhalational therapy in the recent years, a majority of asthma patients may look forward to a healthy life with few symptoms and few exacerbations—as long as their drug is utilized and used correctly. Nevertheless, despite routine preventative therapy, there are still a small number of people with persistent, serious diseases. Bronchial thermoplasty (BT) was created as an add-on therapy for these more severe diseases like asthma.

Bronchial thermoplasty is an advanced treatment for asthma, the world's leading chronic disease. Asthma is one of the most common chronic disorders in children, and it deteriorates with age. It is a complex inflammatory condition brought on by environmental causes or genetic mutations. In asthma, the airway muscles become overly sensitive to different allergens, which causes inflammation of the airway tract's muscular wall and, as a result, narrows the airway channel. Inflammation eventually causes the smooth muscles in the airway tract to thicken, which restricts airflow and interferes with breathing. Asthma is treated by giving patients a variety of medications, such as steroids, beta-agonists, and ibuterol through nebulizers and inhalers. However, bronchial thermoplasty is advised in extreme circumstances, where managing asthma with these drugs is less successful. The global bronchial thermoplasty catheter market is expanding at a rapid pace due to increasing air pollution and the prevalence of dust allergies among people across the globe.

Newest Insights in the Bronchial Thermoplasty Catheter Market

An increase in asthma attacks among people, as well as an increase in the number of hospitalizations for asthma patients have triggered advancements in the field of bronchial thermoplasty catheters. As per a report by Research Dive, the global bronchial thermoplasty catheter market is expected to surpass a revenue of $5,416.8 million in the 2022-2031 timeframe. The North America bronchial thermoplasty catheter market is expected to perceive dominant growth in the years to come. This is because the region has a gigantic demand for bronchial thermoplasty catheters owing to the usage of automobiles as well as government restrictions aimed at decreasing vehicle accidents, which is creating prospects for the bronchial thermoplasty catheter market in the region.

How are Market Players Responding to the Rising Demand for Bronchial Thermoplasty Catheters?

Presently, Boston Scientific is one of the leading manufacturers in the bronchial thermoplasty catheter market. The company is greatly investing in pioneering research and inventions to cater for the rising demand for bronchial thermoplasty catheters. It is focused on planning and devising tactics such as mergers and acquisitions, collaborations, novel advances, and partnerships to reach a notable position in the global market. Apart from this, several other companies have made significant developments in the bronchial thermoplasty catheter arena in the recent years.

For instance:

• In April 2021, Olympus Corporation, a leader in medical technologies worldwide, announced the addition of the 510(k)-cleared H-SteriScope Single-Use bronchoscopes, a range of 5 premium endoscopes used for cutting-edge diagnostic and therapeutic procedures, to its U.S. bronchoscopy portfolio.
   
• In January 2023, Apollo Multispecialty Hospitals Kolkata, one of the top hospitals offering advanced treatment, introduced bronchial thermoplasty, a painless method for the efficient treatment of chronic asthma, for the first time in Eastern India.

COVID-19 Impact on the Global Bronchial Thermoplasty Catheter Market

The unpredicted rise of the coronavirus pandemic in 2020 has adversely impacted the global bronchial thermoplasty catheter market. During the pandemic period, the hospitalization rate for asthma cases was reduced, and only individuals with serious symptoms were admitted. Furthermore, there were just a few companies on the market who provide bronchial thermoplasty catheters. Asthmatic patients took all necessary precautions to stay safe amidst the COVID-19 pandemic. The respiratory system had a great impact of the COVID-19 virus. As a result, patients with COVID-19 infection were hospitalized for treatment, whereas admissions for asthma were declined. The demand for bronchial thermoplasty catheter systems declined during the pandemic since it is used to treat individuals with severe asthma. However, the global market is likely to gain traction post-pandemic crisis, with rising developments in the coming years.